Once the trial protocol is completed and ethical approval obtained, the trial can start in the selected investigational sites. IDDI is not involved in site selection and recruitment. Sites are provided with the investigational treatments and all related trial material (Investigators' Brochure with background information on the new treatments, Case Report Forms to collect patient data, etc.).
Patients are screened at these sites and, if they meet all eligibility criteria for the trial, treated according to the trial protocol.
In comparative trials, patients are allocated one of the treatments being compared according to the randomization method chosen.
IDDI statisticians provide both fixed and dynamic randomization methods, using IDDI's web-based central randomization and drug supply management platform ID-net™ and ID-supply™
